Creating a More Resilient Food Supply

What if we could create a pork protein supply that is more efficient and reliable, improves animal health and welfare, and is better for the environment?

Positive impacts on pigs, people and the planet

PRRS-Resistant Pig

PIC’s PRRS-resistant pig is developed to protect pigs from one of the most devastating diseases in the swine industry today, the Porcine Reproductive and Respiratory Syndrome (PRRS) virus. This solution provides resistance to the impact of the PRRS virus, improving animal health and welfare and reducing the need for antibiotic use1.

Learn more
Resilient Protein, Less Waste

Reducing waste makes protein production more efficient and resilient while creating value throughout the supply chain.

Learn more
Enhanced Pork Supply

These combined benefits will help maintain a more reliable and affordable pork supply for all of us.

Learn more
Environmental Benefits

Healthier pigs consume feed and water resources more efficiently than sick pigs.
This reduces inputs and waste, creating positive environmental outcomes, like reduced greenhouse gases and water use2.

Learn more

Learn more about how the PRRS-resistant pig can benefit you.

A Gene Editing Solution: The PIC PRRS-Resistant Pig Story

The PRRS virus has ravaged the global pork industry for over three decades. Pork producers have relied on vaccines with limited efficacy and on-farm biosecurity protocols to protect their pigs from the PRRS virus – until now. PIC partnered with university researchers to develop a solution using gene editing technology. PIC deleted a small portion of the pig’s DNA that encodes a protein the virus uses to attach, enter and infect the pigs’ cells. Without the ability to attach or bind, the PRRS virus is unable to enter the cell, replicate and infect the pig.

1Research from Iowa State University: Impact of PRRS on need for antibiotic use (2023) & preliminary data from Life Cycle Analysis conducted by Dr Greg Thoma from Colorado State University in 2023.
2Preliminary data from Life Cycle Analysis conducted by Dr Greg Thoma from Colorado State University in 2023.

All claims about safety and efficacy of PIC's PRRS-resistant pig are currently being evaluated by the US FDA.